Filing metadata

Accession number
0000929638-24-004038
Form type
Form 3
Filer
Aclaris Therapeutics, Inc.
CIK
CIK 1557746
Filed
Nov 25, 2024
Reporting period
Nov 18, 2024
Description
Initial ownership

Explore SEC Filings Hub